Abstract
In a recent issue of Molecular Cell, Leu et al. (2009) demonstrate that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects, thereby lending further support to the notion that non-oncogene addiction constitutes a promising target for anticancer therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 176-177 |
| Number of pages | 2 |
| Journal | Molecular Cell |
| Volume | 36 |
| Issue number | 2 |
| DOIs | |
| State | Published - Oct 23 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Animals
- Drug Resistance, Neoplasm/drug effects
- HSP70 Heat-Shock Proteins/metabolism
- HSP90 Heat-Shock Proteins/metabolism
- Humans
- Models, Molecular
- Neoplasms/therapy
- Sulfonamides/pharmacology
Fingerprint
Dive into the research topics of 'Targeting HSP70 for Cancer Therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver